Intuitive Surgical, Inc. $ISRG Shares Sold by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,067 shares of the medical equipment provider’s stock after selling 1,098 shares during the period. Gamco Investors INC. ET AL’s holdings in Intuitive Surgical were worth $4,986,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Chilton Capital Management LLC increased its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the period. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $26,000. Global Financial Private Client LLC increased its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new position in Intuitive Surgical in the first quarter valued at $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. UBS Group upped their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $595.95.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 2,800 shares of the company’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the transaction, the insider owned 18,520 shares in the company, valued at $9,171,844.80. The trade was a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,839 shares of company stock worth $7,896,972 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $471.15 on Thursday. The business’s fifty day moving average price is $501.89 and its 200 day moving average price is $519.66. The firm has a market capitalization of $168.90 billion, a PE ratio of 65.71, a P/E/G ratio of 4.97 and a beta of 1.59. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.